Troutman Pepper Helps Secure Defense Verdict for Johnson & Johnson After 12-day Jury Trial
ATLANTA – Troutman Pepper was part of a national trial team that secured a defense verdict after a 12-day jury trial in a multi-revision pelvic mesh case in federal court in Florida. This most recent trial win follows the team’s successful defense in another ten-day federal jury trial in California. Troutman Pepper has represented Johnson & Johnson in the litigation for over a decade, serving as lead trial counsel as well as being part of the national discovery team.
Troutman Pepper Partner Eric Rumanek served as trial counsel and Associate Brett Tarver played a key support role working with both fact and expert witnesses.
Troutman Pepper’s leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients’ complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm’s litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients’ most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.